NCT01133665View on ClinicalTrials.gov

Cetuximab and Lenalidomide in Head and Neck

PHASE2CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

February 28, 2010

Primary Completion Date

August 31, 2011

Study Completion Date

August 31, 2012

Conditions
Squamous Cell Carcinoma
Interventions
DRUG

Cetuximab and Lenalidomide

The treatment of Head and Neck Cancer with Cetuximab and Lenalidomide

Trial Locations (1)

60637

The University of Chicago, Chicago

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

University of Chicago

OTHER